Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:26 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 17 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Clinical Evidence on Psilocybin and Its Representation in Media Reporting2026-10-20From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy2026-10-01Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder2026-07-16Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA2026-05-01The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons2026-03-27Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review2026-03-09Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin2026-03-01Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention2026-03-01Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms2025-11-25The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin2024-11-01Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice2022-02-23The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin2019-09-01

Related papers

No close related records were found yet.